Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Genenta Science S.p.A
GNTA | US
5.35
USD-0.15
-2.73%
GNTA | US
About Genenta Science S.p.A
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/12/2023
As of date
21/10/2024
Close
5.35
Open
4.78
High
5.92
Low
4.44
Genenta Science S.p.A. a clinical-stage biotechnology company engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is also developing Temferon for use in the treatment of other solid tumor indications locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. In addition it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan Italy.
View LessGNTA | US
Risk
130.1
Sharpe
-0.02
Luna's Score
46/100
Recommendation
Hold
Luna says (GNTA | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
161.3%1 month
130.1%3 months
106.5%6 months
115.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.52
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
-11.48
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-11.69M
MarketCap
97.46M
MarketCap(USD)
97.46M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-45.16
Short ratio
0.64
Short perc.
0.04
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.84
Range1M
3.69
Range3M
3.98
Volumes: Market Activity
Rel. volume
0.67
Price X volume
102.10K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -11.48 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.52 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 106.47 | - | Riskier |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 97.46M | - | Emerging |
